The genomic and transcriptomic profiles of liver metastases from PNETs have identified biallelic loss of MEN1 and DAXX and focal amplification of MYCN concomitant with loss of APC and TP53, suggesting that different cellular pathways may contribute to PNET progression [22]. This evidence concerns the gene MEN1 and primitive neuroectodermal tumor.